Corporate Governance

DiagnoCure is committed to good practices in corporate governance.

DiagnoCure's Board of Directors considers effective corporate governance to be essential to the operations of the Company and to ensure that the Company is managed to enhance shareholder value. The Corporate Governance, Human Resources and Nominating Committee is responsible to ensure that the Company covers all relevant elements of the Corporate Governance's guidelines included in National Instrument 58-201.

Here are the mandates and policies adopted by DiagnoCure with respect to corporate governance:

Corporate Governance

Code of Professional Ethics
Mandate of the Board of Directors
Mandate of the Chairperson of the Board

Committees

Audit and Risk Management Commiittee
Mandate of the Chairperson of the Commiittee

Corporate Governance, Human Resources and Nominating Committee
Mandate of the Chairperson of the Commitee

 

 

 

 

STOCK INFORMATION

Symbol TSX: CUR
Last trade 2.95
Open 2.96
Net change -0.04
High 2.96
Low 2.95
52 week range 1.67 - 3.09
Volume 4,900
As of 2008-07-25
13:46 EST
$CAN. Quotes are delayed.
For information purposes only.

Quick Facts—April 30, 2008

Year-end October 31
Shares Outstanding 41.8 million
Market Capitalization $84.5 million

Documents to Download

PDF Corporate Brochure
PDF Corporate Fact Sheet
PDF Second quarter
PDF 2007 Annual Report

Latest News

Stay Informed

Subscribe to e-mail news alerts